rdf:type |
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0055633,
umls-concept:C0138741,
umls-concept:C0332161,
umls-concept:C0376358,
umls-concept:C0439810,
umls-concept:C0680730,
umls-concept:C1148554,
umls-concept:C1880497,
umls-concept:C1996904,
umls-concept:C2348251
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-7-22
|
pubmed:abstractText |
We ascertained whether plasma chromogranin A enhances the power of serology assessing prostate cancer (PC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0042-1138
|
pubmed:author |
|
pubmed:copyrightInfo |
2005 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-61
|
pubmed:dateRevised |
2007-4-17
|
pubmed:meshHeading |
pubmed-meshheading:16037709-Aged,
pubmed-meshheading:16037709-Aged, 80 and over,
pubmed-meshheading:16037709-Biopsy,
pubmed-meshheading:16037709-Carcinoma,
pubmed-meshheading:16037709-Chromogranin A,
pubmed-meshheading:16037709-Chromogranins,
pubmed-meshheading:16037709-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:16037709-Humans,
pubmed-meshheading:16037709-Male,
pubmed-meshheading:16037709-Middle Aged,
pubmed-meshheading:16037709-Neoplasm Staging,
pubmed-meshheading:16037709-Prostate-Specific Antigen,
pubmed-meshheading:16037709-Prostatic Hyperplasia,
pubmed-meshheading:16037709-Prostatic Neoplasms,
pubmed-meshheading:16037709-ROC Curve,
pubmed-meshheading:16037709-Reproducibility of Results,
pubmed-meshheading:16037709-Tumor Markers, Biological
|
pubmed:year |
2005
|
pubmed:articleTitle |
Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen determination.
|
pubmed:affiliation |
Department of Urology, University of Padova, Padova, Italy. simonetta.fracalanza@unipd.it
|
pubmed:publicationType |
Journal Article,
Comparative Study
|